Aim: To describe the clinical features and genetic basis of distal renal tubular acidosis (dRTA) in Filipino children. Methods: Clinical description and gene analysis of affected members of 7 families. Results: In all affected children, the disease was associated with mutations of the SLC4A1 gene that codes for the bicarbonate/chloride anion-exchanger 1 (AE1, band 3) protein situated in the red cell membrane and the α-intercalated (proton-secreting) cell of the renal collecting duct. In 2 families, affected children were homozygous for a substitution of aspartic acid for glycine in residue 701 of the AE1 protein (G701D); in the other 5 families, affected children were compound heterozygotes of this mutation with the AE1 mutation (Δ400–408) that causes Southeast Asian ovalocytosis (SAO). All affected children had morphological red cell changes that closely resembled SAO, including the children who were homozygous for G701D and did not have the SAO mutation. Homozygous G701D thus produces morphological red cell changes that are not readily distinguishable from SAO. The parents of all 7 families were originally domiciled in the islands of the Visayas group in the central part of the Philippine archipelago. Conclusion: Recessive renal tubular acidosis in Filipinos is usually caused by SLC4A1 mutations, commonly G701D.

Keywords:
Acidosis, Ovalocytosis, Stomatocytosis
1.
Wrong O, Bruce LJ, Unwin RJ, Toye AM, Tanner MJA: Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis. Kidney Int 2002;62:10–19.
2.
Tanphaichitr VS, Sumboonnanonda A, Ideguchi H, Shayakul C, Brugnara C, Takao M, Veerakul G, Alper SL: Novel AE1 mutations in recessive distal renal tubular acidosis. J Clin Invest 1998;102:2173–2179.
3.
Bruce LJ, Wrong O, Toye AM, Young MT, Ogle G, Ismail Z, Sinha AK, McMaster P, Hwaihwanje I, Nash GB, Hart S, Lavu E, Palmer R, Othman A, Unwin RJ, Tanner MJ: Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea. Biochem J 2000;350:41–51.
4.
Yenchitsomanus PT, Vasuvattakul S, Kirdpon S, Wasanawatana S, Susaengrat W, Sreethiphayawan S, Chuawatana D, Mingkum S, Sawasdee N, Thuwajit P, Wilairat P, Malasit P, Nimmannit S: Autosomal recessive distal renal tubular acidosis caused by G701D mutation of anion exchanger 1 gene. Am J Kidney Dis 2002;40:21–29.
5.
Khositseth S, Sirikanaerat A, Wongnenjarat K, Opastirakul S, Khoprasert S, Peuksungnern R, Wattanasirichaigoon D, Thongnoppakhun W, Viprakasit V, Yenchitsomanus PT: Distal renal tubular acidosis associated with Anion Exchanger 1 mutations in children in Thailand. Am J Kidney Dis 2007;49:841–850.
6.
Vasuvattakul S, Yenchitsomanus PT, Vachuanichsanong P, Thuwajit P, Kaitwatcharachai C, Laosombat V, Malasit P, Wilairat P, Nimmannit S: Autosomal recessive distal renal tubular acidosis associated with Southeast Asian ovalocytosis. Kidney Int 1999;56:1674–1682.
7.
Choo KE, Nicoli TK, Bruce LJ, Tanner MJ, Ruiz-Linares A, Wrong OM: Recessive distal renal tubular acidosis in Sarawak caused by AE1 mutations. Pediat Nephrol 2006;21:212–217.
8.
Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, Tanner MJ: Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (band 3, AE1) gene. J Clin Invest 1997;100:1693–1707.
9.
Karet FE: Inherited distal renal tubular acidosis. J Am Soc Nephrol 2002;13:2178–2184.
10.
Nurse GT. Coetzer TL, Palek J: The elliptocytoses, ovalocytosis and related disorders. Baillière’s Clin Haematol 1992;5:187–207.
11.
Livingstone, FB: Frequencies of Hemoglobin Variants: Thalassemia, the Glucose-6-Phosphate Dehydrogenase Deficiency, G6PD Variants, and Ovalocytosis in Human Populations. New York, Oxford University Press, 1985.
12.
Liu SC, Jarolim P, Rubin HL, Palek J, Amato D, Hassan K, Zaik M, Sapak P: The homozygous state for the band 3 protein mutation in Southeast Asian ovalocytosis may be lethal. Blood 1994;84:3590–3591.
13.
Anacleto FE, Bonzon DE, Cutiongco EC, Nicoli TP, Linares AR, Wrong OM: Anion-exchanger-one (AE1) mutations among Filipino children with distal renal tubular acidosis. Pediat Nephrol 2004;19:C183.
14.
Khositseth S, Sirikanaerat A, Khoprasert S, Opastirakul S, Kingwatanakul P, Thongnoppakhun W, Yenchitsomanus P-T: Hematological abnormalities in patients with distal renal tubular acidosis and hemoglobinopathies. Am J Hematol 2008;83:465–471.
15.
King MJ, Bruce L, Whiteway A: The mutant erythrocyte band 3 Southeast Asian ovalocytosis does not bind eosin-5-malemide. Inter J Lab Hematol 2009;31:116–117.
16.
Ranney HM, Rosenberg GH, Morrison M, Mueller TJ: Frequencies of band 3 variants in human red cell membranes in some different populations. Brit J Haematol 1990;75:262–267.
17.
Morris RC, Ives HE: Inherited disorders of the renal tubule; in Brenner BM (ed): The Kidney, ed 5. Philadelphia, Saunders, 1996, pp 4665–4727.
18.
Walsh SB, Borgese F, Gabillat N, Unwin RJ, Guiziouarn H: Cation transport activity of anion exchanger 1 (AE1) mutations found in distal renal tubular acidosis (dRTA): structure-function implications for AE1. Am J Physiol Renal Physiol 2008;295:F343–F350.
19.
Walsh S, Borgese F, Gabillat N, Guizouarn H: Southeast Asian AE1 associated renal tubular acidosis: cation leak is a class effect. Biochem Biophys Res Comm 2009;382:668–672.
20.
Stewart GW: Hemolytic disease due to membrane ion channel disorders. Curr Opin Hematol 2004;11:244–250.
21.
Bruce LJ, Ring SM, Ridgwell K, Reardon DM, Seymour CA, Van Doort HM, Low PS, Tanner MJ: Southeast Asian ovalocytic (SAO) erythrocytes have a cold sensitive cation leak: implications for in vitro studies on stored SAO red cells. Biochem Biophys Acta 1999;1416:258–270.
22.
Honig GR, Larson PS, Maurer H: A new familial disorder with abnormal erythrocyte morphology and increased permeability of the erythrocyte to sodium and potassium. Pediat Research 1971;5:159–166.
23.
Allen SJ, O’Donnell A, Alexander ND, Mgone CS, Peto TE, Clegg JB, Alpers MB, Weatherall DJ: Prevention of cerebral malaria in children in Papua New Guinea by Southeast Asian ovalocytosis band 3. Am J Trop Med Hyg 1999;60:1056–1060.
24.
French DL, Newman PJ, Poncz M: Inherited disorders of platelets; in Scriver CR, Beaudet AL, Valle D, Sly WS (eds): The Metabolic and Molecular Bases of Inherited Disease, ed 8. New York, McGraw Hill, 2001, pp 4473–4504.
25.
Jarolim P, Palek J, Amato D, Hassan K, Sapak P, Nurse GT, Rubin HL, Zhai S, Sahr KE, Liu SC: Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc Nat Acad Sci USA 1991;88:11022–11026.
26.
Liu SC, Zhai S, Palek J, Golan DE, Amato H, Hassan K, Nurse GT, Babona D, Coetzer T, Jarolim P: Molecular defect of the band 3 protein in Southeast Asian ovalocytosis. New Engl J Med 1990;323:1530–1538.
27.
Baehner RL, Gilchrist GS, Anderson EJ: Hereditary elliptocytosis and primary renal tubular acidosis in a single family. Am J Dis Childr 1968;115:414–419.
28.
Yenchitsomanus PT, Sawadee N, Paemanee A, KeskanokwongT, Vasuvattakul S, Bejrandra S, Kunachiwa J, Fuchareon J, Jittphakdee P, Yindee W, Promwong C: Anion exchanger 1 mutations associated with distal renal tubular acidosis in the Thai population. J Hum Genet 2003;48:451–456.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.